![Carey Ng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 11 M $ al 30/09/2026
Carey J.
Ng is currently Managing Director at Mesa Verde Ventures LLC since 2013 and at Mesa Verde Venture Partners LP since 2013.
Dr. Ng serves as Director at Satiogen Pharmaceuticals, Inc., Elysium Therapeutics, Inc., Paradigm Diagnostics, Inc., and MatriSys Bioscience, Inc. Dr. Ng is Independent Director at Immix Biopharma, Inc. since 2019.
Formerly, Dr. Ng was Director at Biscayne Neurotherapeutics, Inc. Dr. Ng earned a doctorate from the University of California, Los Angeles in 2004 and an MBA from the University of California San Diego.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMIX BIOPHARMA, INC. 1,46 % | 22/05/2026 | 1.045.221 ( 1,46 % ) | 11 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMIX BIOPHARMA, INC. | Director/Miembro de la Junta | 01/11/2019 |
Satiogen Pharmaceuticals, Inc.
 Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Director/Miembro de la Junta | - |
Mesa Verde Ventures LLC
 Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Inversor de Capital Privado | 01/01/2008 |
Paradigm Diagnostics, Inc.
 Paradigm Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic systems | Director/Miembro de la Junta | - |
Elysium Therapeutics, Inc.
 Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Director/Miembro de la Junta | - |
MatriSys Bioscience, Inc.
 MatriSys Bioscience, Inc. BiotechnologyHealth Technology Develops rational micro biome therapies | Director/Miembro de la Junta | - |
Mesa Verde Venture Partners LP
 Mesa Verde Venture Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01/12/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
Biscayne Neurotherapeutics, Inc.
 Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Paradigm Diagnostics, Inc.
Paradigm Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic systems | Health Technology |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Commercial Services |
Mesa Verde Venture Partners LP
Mesa Verde Venture Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Biscayne Neurotherapeutics, Inc.
Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Health Technology |
MatriSys Bioscience, Inc.
MatriSys Bioscience, Inc. BiotechnologyHealth Technology Develops rational micro biome therapies | Health Technology |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Immix Biopharma, Inc.
 Immix Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cancer patients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
